HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jörg Bittenbring Selected Research

Jörg Bittenbring Research Topics

Disease

5Neoplasms (Cancer)
01/2023 - 01/2017
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2022 - 01/2018
2Graft vs Host Disease (Graft-Versus-Host Disease)
12/2023 - 01/2017
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 02/2017
1Virus Diseases (Viral Diseases)
01/2018
1Leukemia
02/2017
1Pathologic Complete Response
02/2017
1Hematologic Neoplasms (Hematological Malignancy)
01/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2014

Drug/Important Bio-Agent (IBA)

2idelalisibIBA
02/2022 - 01/2021
1treosulfanIBA
01/2019
1fludarabineIBA
01/2019
118S Ribosomal RNAIBA
01/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2014
1Rituximab (Mabthera)FDA Link
04/2014
1Prednisone (Sone)FDA LinkGeneric
04/2014
1Vincristine (Oncovin)FDA LinkGeneric
04/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2014

Therapy/Procedure

5Stem Cell Transplantation
02/2022 - 01/2017
4Hematopoietic Stem Cell Transplantation
12/2023 - 01/2017
4Transplantation
01/2019 - 01/2017
2Cell Transplantation
01/2023 - 01/2021
1Radiotherapy
04/2014